Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation. (Q39660613)
Jump to navigation
Jump to search
scientific article published on October 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation. |
scientific article published on October 2010 |
Statements
Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation (English)
Takeshi Kawano
Masaharu Akiyama
Miyuki Agawa-Ohta
Yoko Mikami-Terao
Satsuki Iwase
Takaaki Yanagisawa
Hiroyuki Ida
Naoki Agata
Hisashi Yamada
1 October 2010